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Abstract  
Scope:  Unlike other classes of polyphenols, there is a lack of knowledge regarding brown 
seaweed phlorotannins and their bioactivity. We investigated the impact of in vitro 
gastrointestinal digestion and colonic fermentation on the bioactivity of a seaweed 
phlorotannin extract from Ascophyllum nodosum and its high molecular weight (HMW) and 
low molecular weight (LMW) fractions.  
Methods and Results: The highest phlorotannin and total polyphenol (TP) concentration 
was observed in the HMW fraction. Antioxidant capacity broadly followed phlorotannin and 
TP levels, with HMW having the highest activity. Both gastrointestinal digestion (GID) and 
colonic fermentation (CF) significantly affected phlorotannin and TP levels, and antioxidant 
capacity of the extract and fractions. Despite this, in HT-29 cells, all GID extracts 
significantly inhibit cell growth, whereas CF extracts effectively counteracted H2O2 induced 
DNA damage.  
Conclusion:  Although phlorotannins, TP levels and antioxidant power of the extracts 
were strongly reduced after in vitro digestion and fermentation, their anti-genotoxic activity 
and cell growth inhibitory effect in colon HT-29 cells was maintained and enhanced. HMW 
was the most effective fraction, indicating that the high molecular weight phlorotannins 
potentially exert a stronger beneficial effect in the colon. 
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Introduction 
Seaweeds have been traditionally consumed for centuries in coastal regions of Asian 
countries [1], and more recently European countries including Ireland have shown a 
renewed interest in seaweeds that were once a traditional part of the diet [2-5]. The 
gastronomic use of seaweeds has expanded into the European cuisine, and various 
species of edible seaweeds are now increasingly used worldwide as a source of 
components with potential industrial applications  [6-8]. 
Seaweeds are a rich source of a range of bioactive compounds [9-11], including 
polyphenolic compounds [12]. Polyphenols found in algae [13, 14] show some similarities 
to those present in land plants [13-15], Brown seaweeds contain a characteristic class of 
compounds called phlorotannins  [16-19], which are only found in brown seaweeds [20]. 
and  can account for  5 to 15 % of the plant dried weight [15]. They are oligomers and 
polymers of phloroglucinol units, and their molecular weight can vary greatly, from 126 Da 
to 650KDa [12, 19]. Phlorotannins are being increasingly investigated for their vast array of 
bioactivities [14, 21, 22] such as antioxidant [23-27], anti-inflammatory [24, 28, 29], 
antibacterial [30], anticancer [31-35], and antidiabetic [31, 36, 37], showing promising 
potential to develop seaweed-derived products rich in bioactive components with 
commercial potential for food and pharma applications [38, 39]. However the 
gastrointestinal tract may largely impact the structure of phlorotannins during digestion and 
this can have an impact on their bioactivity [40, 41]. The ability of phlorotannins to act as 
effective bioactive molecules in vivo will be dependent on the degree of their 
biotransformation and conjugation during absorption from the gastrointestinal (GI) tract, in 
the liver and finally in cells [40, 42]. In view of this, the way phlorotannins are modified and 
metabolised during gastrointestinal digestion and colonic fermentation, needs to be 
considered, because it will affect their bioactivity [43]. We have recently shown that after 
consumption of a phlorotannin-rich capsule a range of oligomeric metabolites appear in 
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plasma and are excreted in urine, and the data suggest that extensive gastrointestinal 
modifications occur prior to absorption [42].  In the present study, the in vitro 
digestion/fermentation and their impact on antioxidant and anti-genotoxic activity of 
extracts from Ascophyllum nodosum (a common brown alga in British Isles) was 
investigated. An ethanol-based seaweed polyphenol extract (SPE) and its High Molecular 
Weight (HMW) fraction and Low Molecular Weight (LMW) fraction were produced from the 
seaweed and were digested (GID) in vitro to mimic the condition of the human 
gastrointestinal tract [44, 45] and fermented (CF) by using a pH-controlled, stirred, batch-
culture system reflective of the distal region of the human large intestine [46]. We have 
assessed the impact of digestion and fermentation on the in vitro antioxidant capacity, and 
anti-genotoxic potential of the extracts in HT-29 cells. 
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Materials and methods 
Seaweed material.  Fresh Ascophyllum nodosum was supplied by The Hebridean 
Seaweed Company, Isle of Lewis, Scotland in March 2011. The seaweed biomass was 
harvested by hand to ensure quality, cleaned of any contaminating sand and fouling 
organisms and then shipped refrigerated to a processing facility in France where it was 
immediately chopped and frozen. 
Preparation of seaweed extracts.  A novel seaweed polyphenol extract (SPE) from 
Ascophyllum nodosum was produced by CEVA (France) using a proprietary solvent based 
extraction system that was specifically adapted for use with fresh or frozen Ascophyllum 
nodosum.  The extraction step was carried out at room temperature overnight, using an 
ethanol/water (60/40) solvent mix and 400kg of defrosted seaweed. Post extraction, 
insoluble material (>100μm) was removed through a series of filtration steps followed by 
ethanol removal and concentration using a vacuum evaporator.  Approximately half of the 
produced extract was then fractionated using tangential flow ultra-filtration to produce two 
further extracts of high molecular weight (HMW, >10KDa) and low molecular weight (LMW, 
1-10KDa) range, and with varying polyphenol content. The phlorotannins in the extract and 
fractions were characterized by NP-HPLC analysis. Total polyphenols were quantified 
using the Folin-Ciocalteau method as equivalents of phloroglucinol units. 
Simulated Gastro-Intestinal Digestion: The procedure was adapted from Mills et al. and 
McDougall et al. [44, 45] and conducted as previously described [42]. This method 
consists of two sequential stages: gastric digestion and small intestinal digestion with a 
dialysis step. Seaweed extracts and fractions (SPE, HMW, LMW) were dissolved (10g in 
30 ml acidified water pH=2) and pepsin (320 U/ml) was added. Samples were incubated at 
37 °C for 2 h on a shaker covered with foil to exclude light. The pH was adjusted to 7.5 by 
adding few drops of 6M NaOH, and pancreatin (4 mg/ml) and bile extracts (25 mg/ml) 
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were added. The samples were incubated at 37 °C for 2 h on a shaker, transferred into the 
dialysis tubing (100-500 Da, cut-off, 1.8 ml/cm, Spectra/Por, Biotech) and dialysed 
overnight at 4 °C against water (4 L) to remove low molecular weight digested materials. 
The dialysis fluid was changed and dialysis continued for additional 2 h. Digested samples 
(GID) were freeze-dried and stored at -20 °C. Aliquots of digested and dialyzed extracts 
were used in the subsequent in vitro assays and cell culture treatments. 
Colonic Fermentation (Batch Culture):  An aliquot of the digested extracts (GID) was 
subjected to in vitro colonic fermentation procedure, using the previously described 
method [42]. Batch-culture fermentation vessels (300 ml; one vessel per treatment) were 
autoclaved and filled with 135 ml sterilized basal medium. Medium was stirred and gassed 
overnight with O2-free N2. Before addition of the digested extracts (equivalent to 1.5 g of 
undigested extracts), the temperature inside the vessels was set to 37 °C by a circulating 
water bath and the pH was controlled at 6.8 by an electrolab pH controller, in order to 
mimic conditions in the distal region of the human large intestine (anaerobic; 37 °C; pH 
6.8). Vessels were inoculated with 15 ml faecal slurry (1:10, w/v) and batch cultures were 
run for 24 h. Fermented samples were centrifuged at 13200 rcf for 10 minutes and 
supernatants were transferred into the dialysis tubing (100-500 Da, cut-off, 1.8 ml/cm, 
Spectra/Por, Biotech) and dialysed overnight at 4 °C against water (4 L) to remove low 
molecular weight fermented materials. The dialysis fluid was changed and dialysis 
continued for additional 2 h. Samples were stored at -20 °C until subsequent analysis (NP-
HPLC analysis, in vitro assays and cell culture treatments). 
NP-HPLC analysis:  The phlorotannin levels of the non-digested (ND) digested (GID) and 
fermented (CF) extracts were analyzed by normal phase HPLC analysis as previously 
described [42], using an HPLC 1100 series (Agilent) equipped with  LiChrospher Si60-5 
column. The compounds were detected at a wavelength of 268 nm. All data were analyzed 
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by ChemStation software. The phloroglucinol standard was injected at 0.1-100 µg/ml and 
phlorotannins in the extracts were analysed as phloroglucinol equivalents. 
LC-MS analysis:  Further characterization of the non-digested (ND) digested (GID) and 
fermented (CF) extracts was carried out in the negative ion mode using LC-MS/MS 
utilizing electrospray ionisation (ESI) as previously described as previously described [42]. 
Total polyphenol content (Folin-Ciocalteau).  Total polyphenol (TP) content of the non-
digested (ND) digested (GID) and fermented (CF) extracts was determined by the Folin-
Ciocalteau’s method adapted from Yuan et al. [47]. 100 μl of sample were mixed with 50 μl 
of 2M Folin-Ciocalteau’s reagent and left at room temperature for 3 min. Then 200 μl of 
20% Na2CO3 were added and the mixture incubated at room temperature in the dark for 
45 min before transferring 150 μl to a 96 microwell plate in duplicate. Absorbance was 
measured at 730 nm on a GENios TECAN microplate reader using phloroglucinol as the 
standard. TP content of the extracts was expressed as µg/mg phloroglucinol equivalents. 
Antioxidant capacity (TEAC assay).  The antioxidant capacity of the ND, GID and CF 
extracts was determined by the Trolox Equivalent Antioxidant Capacity (TEAC assay) 
assay method [48] as follows: A stable stock solution of ABTS˙+ was produced by reacting 
a 7 mmol/L aqueous solution of ABTS with 2.45 mmol/L potassium persulfate (final 
concentration) and allowing the mixture to stand in the dark at room temperature for 12–16 
h before use. An ABTS˙+ working solution was obtained by diluting the stock solution in 
ethanol to an absorbance of 0.70 (730nm). 15 μl of each sample were mixed with 450 μl of 
ABTS˙+ working solution and left at room temperature for 5 min. 150 μl of sample 
solutions were transferred to microwell plate in duplicate and absorbance was measured 
at 730 nm on the GENios TECAN microplate reader. Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid) was used as the standard for a calibration curve. 
Results from TEAC assay were quantified as μmol/mg Trolox equivalents. 
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HT-29 cell culture:  HT-29 human colorectal adenocarcinoma cells were cultured in high 
glucose (4.5g/L) Dulbecco’s modified Eagle’s medium (DMEM) containing Na pyruvate, 
supplemented with 10 % heat-inactivated bovine serum, 2 mM L-glutamine, 100 U/ml 
penicillin, and 100 g/ml streptomycin.  Cells were kept in 75cm2 culture flasks at 37°C, 
5% CO2 and passaged once a week. Spent media was replaced 1 day after seeding and 
every 2-3 days thereafter. 
Treatment of HT-29 cells for DNA damage assay (COMET): HT-29 cells were prepared 
as follows: 1 x 106 cells/well were seeded on 6 well plates (0.5ml/well) and incubated 
overnight at 37 °C, 5% CO2 before treatment. Cells were treated with 100μg/ml of extracts 
and incubated at 37 °C, 5% CO2 for 24h. After the incubation time the media was 
removed, and cells were trypsinized, washed with PBS, centrifuged (1800rpm, 5 min), re-
suspended in serum-free media and counted with trypan blue staining. The cell 
concentration was adjusted to 1.5 x 106 cells/ml and subjected to the Comet assay. 
COMET assay: An alkaline COMET assay was performed as described by Gill et al. [49] 
on HT-29 cells suspended in 1 ml phosphate buffer saline (PBS). Cells aliquots were 
incubated for 5 min on ice in presence or absence of hydrogen peroxide (75μM). Each 
sample was analyzed in triplicate, along with positive and negative controls. Cells were 
washed with PBS and centrifuged (380 g for 8 minutes) to remove residual H2O2, re-
suspended in 0.85% low melting agarose and added into fully frosted slides coated with 
normal melting agarose. Slides were dried (4 °C, 10 min) and cells were lysed by 
incubating with lysis buffer containing 1% Triton X-100 (4 °C, 1 h). Slides were transferred 
into the electrophoresis tank, covered with alkaline buffer and allowed to unwind for 20 
minutes prior to run (20 minutes, 26 volts, 300 mA at 4 ºC). After 3 washes in neutralizing 
buffer the slides were stained with ethidium bromide (20μg/ml), dried and analysed using 
an Epi-fluorescent Nikon microscope connected with a digital camera. Imaging was 
9 
 
 
 
performed using a computerized image analysis system (Komet 5.5, Andor Bio-Imaging). 
Fifty cells per slide were analyzed randomly and the data were presented as the 
percentage of tail DNA. 
Treatment of HT-29 cells for cell growth assay (SRB):  HT-29 cells were seeded at low 
confluence in 24-well plates (2.5 × 104 per well) and were treated with the extracts (100, 
250, 500 µg/ml) or vehicle 8 h after seeding. Following 48 h incubation (37 °C, 5% CO2), 
cells were fixed and cell biomass was determined using the SRB assay [50].   
SRB assay: sulforodhamine B (SRB) assay was performed as previously described [50]. 
Briefly, cells were fixed by the addition of 125 µl ice-cold TCA (10 % final concentration; 4 
°C; 1 h). After fixing, media was removed, cells were washed and total biomass was 
determined using SRB (250 µl of 0.4 % SRB; 0.5 h).  Unincorporated dye was discarded 
by washing with 1 % acetic acid, whilst cell incorporated dye was solubilised using Tris 
Base (10 mM, pH 10.5).  Dye incorporation, reflecting cell biomass, was measured at 492 
nm, using a GENios microplate reader (TECAN, Reading, UK). 
Statistical analysis:  The statistical evaluation of the results was performed using 
GraphPad Prism version 7 (GraphPad Software, San Diego, CA, USA). Grouped data 
format was used, and the statistical analysis performed was a two-way analysis of 
variance (ANOVA) followed by a Bonferroni post-hoc t-test. Statistical significance was set 
at P < 0.05.  
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Results  
Seaweed polyphenol extract characterization:  The chromatogram (Figure 1) illustrates 
the traces obtained by NP-HPLC with diode array detection after injecting a water solution 
of the SPE and the HMW (>10KDa) and LMW (1-10KDa) fractions. The 3 chromatograms 
show a number of peaks eluting, predominantly at 20-70 min, the elution time being 
directly related to the molecular weight of the phlorotannins, where low molecular weight 
components will elute early and high molecular weight components will appear at later 
retention times. A calibration curve of phloroglucinol was used to quantify all the 
phlorotannins in the samples as phloroglucinol equivalents. The SPE, HMW and LMW 
extracts comprised a wide range of molecular weight of phloroglucinol derivatives with a 
total phlorotannin concentration of 358.9 µg/mg (SPE), 938.2 µg/mg (HMW), 374.5 µg/mg 
(LMW), as phloroglucinol equivalents.  
In vitro digestion and characterisation: SPE, HMW and LMW were subjected to in vitro 
digestive and fermentative processes and simulation of absorption into the circulation 
(Figure 2). , Samples from the procedure were analysed by NP-HPLC with diode array 
detection. Figure 3 shows the traces obtained for the 3 extracts (SPE, HMW and LMW) 
when undigested (black trace, ND), digested (grey trace, GID) and fermented (black 
dashed trace, CF) aliquots were injected. For all 3 extracts, we observed a reduction of the 
components eluting at 20-70 min after GID (grey line), which is limited for HMW (5.4%), 
and much more important for SPE (59.0%) and LMW (52.8%).  After the CF procedure 
(black dashed line) we observed a further reduction of the peaks eluting at 20-70 minutes, 
with reduction levels of 96.8 % (SPE), 89.9 (HMW) and 68.0% (LMW). In parallel, we 
observe the appearance and/or increase of some large peaks eluting at earlier timepoints, 
0-20min. In our Normal Phase chromatographic conditions, the elution times are correlated 
to the size/molecular weight of the phlorotannin units, and therefore our results indicated 
the progressive reduction of the larger molecular weight polymeric phlorotannins into low 
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molecular weight forms (oligomeric units, degradation products) during simulated 
gastrointestinal digestion and in vitro colonic fermentation. It is interesting to note that the 
very high molecular weight component present in the HMW fraction (≥1KDa) were reduced 
to a very limited extent under gastric and small intestinal conditions (5.4%), whereas they 
were more significantly reduced during colonic fermentation conditions (89.9%). 
Additionally, the samples were analysed by LC-MS/MS utilizing electrospray ionisation 
(ESI) in negative ion mode (Supplementary tables 1 and 2) as previously described [42]. In 
both GID and CF extracts, we found a range of newly formed metabolites, and we were 
able to identify molecular ions and fragments corresponding to hydroxytrifuhalol A (405), 
the C-O-C dimer of phloroglucinol (247), the dimer diphlorethol/ difucol (249) and 7-
hydroxyeckol (387), in accordance with what observed in our previous study [42]. 
Total Polyphenol content and antioxidant capacity. 
The three extracts (SPE, HMW and LMW) undigested (ND), digested (GID) and fermented 
(CF) were assessed for TP content (Figure 4A) and for in vitro antioxidant capacity (Figure 
4B) using the TEAC assay method. As shown in Figure 4A, before digestion (ND) the high 
molecular weight fraction HMW had the highest TP content (441.6 µg/mg), followed by 
SPE (211.9 µg/mg) and LMW (155.3 µg/mg). The TP content of all extracts was 
significantly reduced by GID (P<0.001 vs. ND), with reduction levels of 81.7% (SPE), 
40.4% (HMW) and 64.7% (LMW). After CF, the TP levels were further reduced (P<0.001 
vs. ND) to 99.5% (SPE), 86.5% (HMW) and 92.5% (LMW) of the initial levels measured in 
the ND extracts.  In accordance with TP results, the antioxidant test (Figure 4B) showed 
that before digestion the high molecular weight fraction HMW had the highest TEAC value 
(3.7 µmol/mg), followed by SPE (2.6 µmol/mg) and LMW (2.1 µmol/mg). Digestion 
significantly reduced the TEAC value of all extracts (P<0.001 vs. ND), with reduction levels 
of 79.5% (SPE), 27.4% (HMW) and 68.7% (LMW). After CF, the TEAC values were further 
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reduced (P<0.001 vs. ND) to 94.8% (SPE), 82.4% (HMW) and 84.0% (LMW) of the initial 
levels measured in the ND extracts. It is interesting to note that TP levels and TEAC 
values of the HMW fraction were affected less than the HMW fraction by the GID 
procedure.  
DNA damage in human colon cells HT29 (COMET assay) 
HT-29 cells were exposed to the GID and CF extracts (100 μg/ml, 24 h) and we tested the 
ability of each extract (SPE, HMW, LMW) to reduce H2O2 induced cellular DNA damage 
(COMET assay).  As shown in Figure 5, a low level of DNA damage (% of DNA in tail) was 
measured in the controls whereas in cells challenged with H2O2, the DNA damage was 
significantly increased (P<0.001). Among the extracts subjected to the GID procedure, 
only HMW was able to significantly reduce DNA damage compared to H2O2 alone 
(P<0.01), whereas SPE and LMW were not effective (P>0.05). When analysing the effects 
of the extracts subjected to CF procedure, however, all extracts were significantly effective 
(P<0.001) in reducing the DNA damage induced by H2O2, despite the loss of antioxidant 
capacity of the CF extracts. The statistical analysis also highlighted that within each group 
(GID and CF) the effect of HMW was significantly higher than SPE and LMW (P<0.05). 
Cell growth inhibition in human colon cells HT29 (SRB assay):   
HT-29 cells were exposed to the GID (Figure 6A) and CF (Figure 6B) extracts (100, 250 
and 500 μg/ml, 72 h) and we tested the ability of each extract (SPE, HMW, LMW) to 
induce cell growth inhibition by measuring changes in the cell biomass (SRB assay).   
Fig.6A shows that the lower concentration tested (100 µg/ml) was ineffective (P>0.05), 
whereas at higher doses all GID extracts significantly inhibited (P<0.01) HT-29 cell growth, 
with HMW being the most effective. In contrast, when the cells were treated with the CF 
extracts (Figure 6B), only HMW was able to significantly inhibit (P<0.05) the growth of the 
cells at the concentrations 250 and 500 µg/ml. it is interesting to note that the HMW seems 
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to exert the strongest effects in both GID and CF groups, and again it is worth highlighting 
the fact that the CF extract is able to exert a significant effect despite the loss of 
antioxidant capacity. 
 
 
Discussion 
Over the past few years, significant interested has developed in bioactives from brown 
seaweed [11, 51] and phlorotannins have gained attention for their potential beneficial 
effects for human health [11] However, due to the many analytical challenges faced when 
conducting phlorotannin analysis, knowledge on phlorotannin bioavailability, 
gastrointestinal modifications and their impact on bioactivity is scarce or absent.  We 
recently reported [42] for the first time that seaweed phlorotannins are metabolized to 
small oligomeric units, and their time of appearance in urine and plasma is indicative of a 
predominant large intestinal metabolic transformation. The analysis of phlorotannins is 
challenging due to high range of molecular weight present, and their characterisation is 
complicated further by the lack of commercially available standards, therefore in our recent 
work we made use of both reverse phase (RP) and normal phase (NP) HPLC 
chromatography coupled to diode array (DAD) and mass spectrometry detection to try and 
understand how phlorotannins are digested and absorbed into the circulation, and what 
kind of modifications can occur in the small and large intestine prior to absorption [42]. NP-
HPLC coupled to DAD is indeed a simple and useful tool for the analysis of oligomeric and 
polymeric phlorotannins [12], and we used it in the present study  to characterize 
phlorotannins in the 3 extracts, and to understand the modifications they are subjected to 
during gastrointestinal digestion and colonic fermentation at different degrees of 
polymerization. Our results highlight a large reduction in the amount of the polymeric forms 
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eluting a late retention times in our NP method. The forms with molecular weight > 10KDa 
were only marginally affected by the GID condition, whereas they were largely reduced 
following CF in the presence of the large intestinal microbiota. In addition, further 
characterization via LC-MS/MS analysis of the GID and CF extracts has indicated the 
presence of some oligomeric phlorotannins (hydroxytrifuhalol A, diphloretol/difucol, 7-
hydroxyeckol, C-O-Cdimer of phloroglucinol), in addition to a range of newly formed, 
unknown metabolites. In parallel, using traditional in vitro tests for TP content and 
antioxidant scavenging capacity, we observed a reduction of both after in vitro GID and 
CF. These results imply that the putative beneficial health effects of polyphenolic 
compounds cannot be meaningfully assessed by measuring their total polyphenolic 
content and scavenging potential without taking into consideration the impact of digestive 
and fermentative processes in the gastro-intestinal tract. In the upper gastrointestinal tract, 
where GID occurs, dietary polyphenols are exposed to specific pH conditions, and act as 
substrates for a number of enzymes found both in the stomach and small intestine [40].  
Further transformations can occur in the colon, where the enzymes of the gut microbiota 
act to breakdown complex polyphenolic structures to smaller units.  Bacterial enzymes 
may catalyse many reactions including hydrolysis, dehydroxylation, demethylation, ring 
cleavage and decarboxylation as well as rapid de-conjugation [52]. 
In addition, our study made use of a simple cell culture system (colonic HT-29 cells), to 
assess changes in bioactivity of phlorotannins after digestion and fermentation. We stress 
the attention on the fact that despite the significant reduction of phlorotannins, TP and 
antioxidant potential in GID conditions, the HMW extract exerted a significant protective 
effect in counteracting H2O2-induced DNA damage. In addition, after CF all extracts 
showed a further reduction of TP and antioxidant capacity, thus they were able to 
significantly reduce H2O2-induced DNA damage, indicating how the potential beneficial 
effects of the extracts are not linked to their in vitro antioxidant potential.  Our results are 
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consistent with observations of (poly)phenolic compounds from other terrestrial dietary 
sources [53-56]. Our results also highlight the strong impact of GID and CF on the ability of 
the extracts to induce cell growth inhibition on HT-29 cells. In this case, all GID extracts 
exerted a significant effect, whereas after CF only HMW was able to significantly inhibit the 
growth of the cells. Therefore we highlight the differential effects of GID and CF, with CF 
more strongly influencing the anti-genotoxic potential of the extract, whereas GID has 
more strongly impacted the potential of the extracts to induce cell growth inhibition. Our 
data indicates that the gut microbiota metabolism of the seaweed extracts increased their 
ability to counteract the H2O2 induced DNA damage, whereas it reduced the ability of the 
extracts to inhibit cell growth. 
Therefore, the present work gives some important insights on the role of gastrointestinal 
digestion and colonic biotransformation on phlorotannin bioactivity in the colon, providing a 
basis for further investigating the seaweed-derived bioactive components in vivo, and help 
to elucidate their mechanism of action.  
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Figure Legends: 
Figure 1. Chromatographic separation of phlorotannins contained in the seaweed 
polyphenol extract (SPE), High Molecular Weight (HMW) and Low Molecular Weight 
(LMW) fractions by Normal-Phase HPLC with diode array detection (268nm).  
Figure 2. Digestion scheme. Schematic illustration of the simulated Gastro-
Intestinal Digestion (GID) and Colonic Fermentation (CF) procedures. 
Figure 3. HPLC analysis/digestion. Normal-Phase HPLC analysis (268nm) of the 
extracts showing the impact of digestion and fermentation on the phlorotannin 
content. Black line = Non-Digested (ND); grey line = Gastro-Intestinal Digestion 
(GID); black dashed line = Colonic Fermentation (CF). 
Figure 4. In vitro activity of seaweed extracts. Total Polyphenol content (A) and 
Trolox Equivalent Antioxidant Capacity (B). Data are means of 3 separate 
experiments, each performed in 3 replicates (n = 9), and presented as mean ±SEM. 
Statistical analysis of grouped data was conducted by Two-way ANOVA, using a 
Bonferroni post-hoc test to analyse simple effects of the digestion procedure in each 
extracts. In all groups, P<0.001 vs. ND. 
Figure 5. DNA damage (% cells in tail) measured by COMET assay in HT-29 cells 
treated with digested (GID) and fermented (CF) seaweed extracts. Data are means 
of 3 separate experiments, each performed in 3 replicates (n = 9), and presented as 
mean ±SEM. Statistical analysis of grouped data was conducted by Two-way 
ANOVA, using a Bonferroni post-hoc test to analyse simple effects of the treatments 
for each digestion procedure. A = P < 0.05 vs. control; a = P < 0.05 vs. H2O2 
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Figure 6. SRB assay.  Cell growth inhibition induced by in Ht-29 cells pretreated 
with SPE, HMW and LMW extracts (100, 250 and 500 μg/ml) for 24h.   GID extracts 
(A) and CF extract (B). Data are means of 3 separate experiments, each performed 
in 3 replicates (n = 9), and presented as mean ±SEM. Statistical analysis was 
conducted by Two-way ANOVA with Bonferroni post-hoc test. a = P < 0.05 vs. 
control; A = P < 0.05 vs. control H2O2. 
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Figure 6 
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Supporting Information tables: 
 
SI Table1. LC-MS analysis in negative ion mode of the in vitro digested (GID) seaweed extracts 
RT (min) [M-H]-  (m/z) MS2 (m/z) tentative identification 
SPE 
1.7 289 261 221 175  Unknown 
1.75 317 249 225 181 113 Unknown 
2.70 405 387 191   hydroxytrifuhalol A 
5.00 247 203    C-O-C dimer of phloroglucinol  
5.70 249 231 207 163 113 diphlorethol / difucol 
9.30 387 369 230   7-hydroxyeckol 
HMW 
1.65 249 181 113     Unknown 
1.75 317 249 225 181 113 Unknown 
2.70 405 387 191   hydroxytrifuhalol A 
5.70 249 231 207 163 113 diphlorethol / difucol 
9.30 387 369 230   7-hydroxyeckol 
LMW 
1.75 317 249 225 181 113 Unknown 
2.70 405 387 191   hydroxytrifuhalol A 
5.00 247 203    C-O-C dimer of phloroglucinol  
9.30 387 369 230     7-hydroxyeckol 
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SI Table2. LC-MS analysis in negative ion mode of the in vitro fermented (CF) seaweed extracts 
RT (min) [M-H]-  (m/z) MS2 (m/z) tentative identification 
SPE 
1.7 289 261 221 175   Unknown 
1.75 317 249 225 181 113 Unknown 
1.8 327 269 211 93  Unknown 
3.3 497 479 353 205  tetrafucol, fucodiphlorethol 
9.30 387 369 230     7-hydroxyeckol 
HMW 
1.75 317 249 225 181 113 Unknown 
1.80 327 269 211 93  Unknown 
9.30 387 369 230   7-hydroxyeckol 
LMW 
1.75 317 249 225 181 113 Unknown 
1.80 327 269 211 93  Unknown 
3.3 497 479 353 205  tetrafucol, fucodiphlorethol 
9.3 387 369 230     7-hydroxyeckol 
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Graphical abstract text: 
Effect of simulated gastrointestinal digestion and fermentation on polyphenolic 
content and bioactivity of brown seaweed phlorotannin-rich extracts. 
Giulia Corona1,2,*, Maria Magdalena Coman2,3, Yuxuan Guo2, Sarah Hotchkiss4, Chris Gill5, 
Parveen Yaqoob2, Jeremy P.E. Spencer2 and Ian Rowland2 
 
 
This study examines the impact of in vitro gastrointestinal digestion and colonic fermentation 
on the stability and bioactivity of a seaweed phlorotannins. An ethanolic extract from 
Ascophyllum nodosum rich in phlorotannins, and its high molecular weight (HMW) and low 
molecular weight (LMW) fractions were utilized. Both gastrointestinal digestion (GID) and 
colonic fermentation (CF) significantly affected polymeric phlorotannins, total polyphenol 
levels, and antioxidant activity of the extract and fractions. Despite this, the anti-genotoxic 
activity and cell growth inhibitory effect of the extracts in colon HT-29 cells was maintained 
and enhanced. HMW was the most effective fraction, indicating that the high molecular 
weight phlorotannins potentially exert a stronger beneficial effect in the colon. 
 
 
